Verona, NJ, United States of America

Arnold Brossi

This inventor holds 2 USPTO granted patents. Top assignee: Hoffmann-La Roche Inc.. Active years: 1976-1977.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Arnold Brossi. Retrieved from https://idiyas.com/inventor/arnold-brossi-v33r64tn

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1976-1977

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Arnold Brossi

Introduction

Arnold Brossi is a notable inventor based in Verona, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel heterocyclic compounds. With a total of 2 patents, his work has implications for various therapeutic applications.

Latest Patents

Brossi's latest patents include "Intermediates in the preparation of 2,3,4,5-tetrahydro-1H-3-benzazepines" and "6-(3,4-Methylenedioxy-6-benzylalkylaminoethylphenylacetyl)benzoic acid." The first patent discloses a process for preparing heterocyclic compounds that exhibit analgesic, appetite suppressant, and anti-edema activity. The second patent relates to the preparation of novel rheadan-type alkaloids and intermediates that are pharmaceutically useful.

Career Highlights

Brossi has been associated with Hoffmann-La Roche Inc., a leading company in the pharmaceutical industry. His work has contributed to advancements in drug development and therapeutic solutions.

Collaborations

Some of his notable coworkers include Benjamin Pecherer and Robert Sunbury. Their collaborative efforts have further enhanced the innovative research environment at Hoffmann-La Roche Inc.

Conclusion

Arnold Brossi's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the development of important therapeutic compounds.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…